LobbyingNational Assn for Behavioral Healthcare lobbying by quarter
National Assn for Behavioral Healthcare's latest lobbying report covers Q2 2026, at $140K. The four quarters Q4 2025–Q3 2026 total $420K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid.
National Assn for Behavioral Healthcare
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $420K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $160K | 1 |
| Q1 2023 | $270K | 1 |
| Q2 2023 | $240K | 1 |
| Q3 2023 | $190K | 1 |
| Q4 2023 | $200K | 1 |
| Q1 2024 | $170K | 1 |
| Q2 2024 | $150K | 1 |
| Q3 2024 | $90K | 1 |
| Q4 2024 | $140K | 1 |
| Q1 2025 | $140K | 1 |
| Q2 2025 | $140K | 1 |
| Q3 2025 | $140K | 1 |
| Q4 2025 | $140K | 1 |
| Q1 2026 | $140K | 1 |
| Q2 2026 | $140K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$2.5M · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Education, Dept of15 reports
- Health & Human Services, Dept of (HHS)15 reports
- HOUSE OF REPRESENTATIVES15 reports
- Labor, Dept of (DOL)15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseNatl Assn for Behavioral Healthcare | $2.5M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| SCOTT DZIENGELSKI | Rep. Murphy (PA-18): Leg. Dir. (2015-2017), Sr. Leg. Asst. (2013-2015), Leg. Asst. (2012-2013), Leg. Corr. (2011-2012), Staff Asst. (2010-2011); Energy and Commerce Committee: Staff (2015-2017). | Q2 2026 |
| ANDREW CHARLES DODSON | Leg Director, Rep. Max Sandlin, (1/1997 - 4/1999) | Q4 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q4 2025 | In-house | $140K |
| 07/20for Q1 | In-house | $140K |
| 07/20for Q2 | In-house | $140K |
| 04/20for Q1 | In-house | $140K |
| 01/20for Q4 2025 | In-house | $140K |
| 25/10/20for Q3 2025 | In-house | $140K |
| 25/10/20for Q2 2025 | In-house | $140K |
| 25/07/21for Q2 2025 | In-house | $140K |
| 25/04/21for Q1 2025 | In-house | $140K |
| 25/01/21for Q4 2024 | In-house | $140K |
| 24/10/21for Q3 2024 | In-house | $90K |
| 24/07/23for Q2 2024 | In-house | $150K |
| 24/04/22for Q1 2024 | In-house | $170K |
| 24/01/22for Q4 2023 | In-house | $200K |
| 23/10/20for Q3 2023 | In-house | $190K |
| 23/07/20for Q2 2023 | In-house | $240K |
| 23/04/20for Q1 2023 | In-house | $270K |
| 23/01/20for Q4 2022 | In-house | $160K |